Search Results 7311-7320 of 28480 for oral

1. Curriculum Timeline - Curriculum - Medical Scientist Training Program (M.D.-Ph.D.) - Mayo Clinic College of Medicine & Science

   The retreat includes oral and poster presentations, program discussion, social time, and a lecture given by a Mayo Clinic physician-scientist or alum of the ...

2. Mayo Clinic's Cystic Fibrosis Foundation-designated CF care center

   Outpatient treatment, when possible, is preferred, but a lack of response to oral antibiotic therapy often necessitates hospital admission for provision of ...

3. E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) - Mayo Clinic

   - Able to swallow and retain oral medication with no clinically significant gastrointestinal abnormalities that may alter absorption, such as malabsorption ...

4. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

   Participants who are able to switch to low molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) prior to date of registration (and plan to ...

5. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Prior oral corticosteroid therapy for an indication other than CLL will not be considered "prior treatment." Previous use of corticosteroids in the ...

6. Publications - Paul M. McKie, M.D. - Mayo Clinic

   Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure. Circulation. 2005 Aug 9; 112(6): ...

7. Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma - Mayo Clinic

   * Unable to swallow oral drugs. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 1/28/2025. Questions regarding ...

8. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

9. Throat cancer - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...

10. A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

    * Initiated or altered therapy with oral or inhaled antibiotics as chronic treatment for NCFBE within 3 months prior to screening. * Initiated or altered ...